L
Lisa Ondrejcek
Publications - 4
Citations - 2850
Lisa Ondrejcek is an academic researcher. The author has contributed to research in topics: Internal medicine & Pre-exposure prophylaxis. The author has an hindex of 2, co-authored 2 publications receiving 2516 citations.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Aloysious Kakia,Josephine Odoyo,Akasiima Mucunguzi,Edith Nakku-Joloba,Rogers Twesigye,Kenneth Ngure,Cosmas Apaka,Harrison Tamooh,Fridah Gabona,Andrew Mujugira,Dana Panteleeff,Katherine K. Thomas,Lara Kidoguchi,Meighan Krows,Jennifer Revall,Susan Morrison,Harald S. Haugen,Mira Emmanuel-Ogier,Lisa Ondrejcek,Robert W. Coombs,Lisa M. Frenkel,Lisa M. Frenkel,Craig W. Hendrix,Namandjé N. Bumpus,David R. Bangsberg,Jessica E. Haberer,Wendy S. Stevens,Jairam R. Lingappa,Connie Celum +49 more
TL;DR: Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Journal ArticleDOI
Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention
Andrew Mujugira,Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,Linda E Barnes,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,Carey Farquhar,Grace John-Stewart,Lara Kidoguchi,Dana Panteleeff,Meighan Krows,Heena Shah,Jennifer Revall,Susan Morrison,Lisa Ondrejcek,Charlotte Ingram,Robert W. Coombs,Jairam R. Lingappa,Connie Celum +32 more
TL;DR: Couples at high risk of HIV-1 transmission were rapidly recruited into the Partners PrEP Study, the largest efficacy trial of oral PrEP.
Journal ArticleDOI
Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya
Smritee Dabee,Victor Mudhune,Eleanor McLellan-Lemal,Siobhán O'Connor,Betty Njoroge,Beatrice Nyagol,Andrea R. Thurman,Eunice Akinyi Ouma,Renee Ridzon,Jeffrey Wiener,Melanie A. Gasper,Colin Feng,Shannon A. Allen,Gustavo F. Doncel,Heather B. Jaspan,Nelly Mugo,Renee Heffron,Richard Ndivo,Maxcine Oguta,Haynet Opon,Dorine Awili,A. M. Mithika,Epines Chavangi,Jecinter Oruko,John Okanda,Arthur Ogendo,Elizabeth Ayuo,Evans Odipo,Vitalis Sewe,Boaz Kerubo,Calvin Mbeda,Eucabeth Awuonda,Isdorah Odero,Emily Anyango,Erica Mimba,Fredrick Leica Oloo,Richard Ochieng Odipo,Valarie Opollo,Emily Mogire Kerubo,Fredrick O Omondi,Angela O. Grassi de Gende,Kelvin Wandera,Carolyne Achieng Juma,Alice Nakiyemba Were,Phoebe Ogutu,Susan Aremo,Philister Adhiambo Madiega,Daniel Ogando,Judy Arego,Mary A. Awuor Otieno,Rosemary Akello,Kenneth Ondenge,Teresa Omoro,Caren Amondi,Kimberly D. McCarthy,Susan Morrison,Meighan Krows,Connie Celum,Abenan L. Ouattara,Nazita Yousefieh,Jill L. Schwartz,Allison Matthews,Shannon Allen,Elizabeth Russell,Karen A. Near,Taraz Samandari,Stacie R. Deaton,Lee Claypool,Joshua E Betts,Richard E. Haaland,Amy Martin,Jeffrey J. Fountain,Terry A. Jacot,D. Erikson,Steven W. Blue,B.R. Remington,Bruce Frank,Nina Isoherranen,Harald S. Haugen,Jared M. Baeten,Katherine K. Thomas,Athena P. Kourtis,Naomi K. Tepper,Lisa Ondrejcek,J Williams,Matt Johnson,Joe Jiang,Sue Marie Peacock,Deborah Donnell +88 more
TL;DR: In this article , the authors investigated the influence of 90 days continuous-delivery tenofovir (TFV) intravaginal rings (IVRs) with/without levonorgestrel (LNG) on the genital microbiota of Kenyan women.
Journal ArticleDOI
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults
Zachary K. Sagawa,Cristina Goman,Aude Frevol,Azra Blazevic,Janice M. Tennant,Bridget S. Fisher,Tracey A. Day,Stephen Jackson,Franck Lemiale,Leon Toussaint,Irene Kalisz,Joe Jiang,Lisa Ondrejcek,Raodoh Mohamath,Julie Vergara,Alan Lew,Anna Marie Beckmann,Corey Casper,Daniel F. Hoft,Christopher Cox +19 more
TL;DR: A randomized, double-blinded Phase 1 clinical trial (NCT03722472) evaluating the safety, tolerability, and immunogenicity of a thermostable lyophilized single-vial presentation of the ID93 + GLA-SE vaccine candidate compared to the non-thermostable two-Vial vaccine presentation in healthy adults is presented in this article .